Marrazzo Jeffrey D 4
4 · Prime Medicine, Inc. · Filed Mar 4, 2024
Insider Transaction Report
Form 4
Marrazzo Jeffrey D
Director
Transactions
- Award
Stock Option (right to buy)
2024-02-29+250,000→ 250,000 totalExercise: $8.63Exp: 2034-02-28→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest in full on the one-year anniversary of the date of grant, subject to the Reporting Person's continued service through such vesting date.